化合物CCT018159 T21872
品牌 | 厂商性质 | 产地 | 货期 |
---|---|---|---|
TargetMol | 生产商 | 美国 | 现货 |
性能特点
生化试剂,可用于动物细胞实验
规格 | CAS号 | 价格 | 操作 |
---|---|---|---|
10 mg | 171009-07-7 | ¥1,150.00 | 询底价 |
100 mg | 171009-07-7 | ¥4,930.00 | 询底价 |
5 mg | 171009-07-7 | ¥742.00 | 询底价 |
50 mg | 171009-07-7 | ¥3,460.00 | 询底价 |
25 mg | 171009-07-7 | ¥2,310.00 | 询底价 |
1 mg | 171009-07-7 | ¥315.00 | 询底价 |
Product Introduction
Bioactivity
英文名: CCT018159
描述: CCT018159 是一种 3,4-二芳基吡唑间苯二酚,是一种 ATP 竞争性HSP90ATPase 抑制剂,对人 Hsp90β 和酵母 Hsp90 具有抑制作用,IC50分别为 3.2 和 6.6 μM。CCT018159 抑制与侵袭和血管生成有关的关键内皮细胞和肿瘤细胞功能。CCT018159 引起与 G1 期阻滞相关的细胞抑制并诱导细胞凋亡。
体外活性: CCT018159 (100 nM-10 μM) decreased POMC mRNA levels in AtT-20 cells and ACTH levels in the culture medium of these cells, suggesting that CCT018159 suppresses ACTH synthesis and secretion in corticotroph tumor cells. CCT018159 also decreased cell proliferation and induced apoptosis. FACS analyses revealed that CCT018159 agents increased the percentage of AtT-20 cells in the G2/M phase. CCT018159 decreased cell proliferation, presumably due to the induction of cell death and arrest of the cell cycle in AtT-20 cells.[1]
体内活性: CCT018159 (4 mg/mouse; s.c.; ones daily for 14 days; AtT-20-xenografted mice) reduced tumor weight compared to AtT-20-xenografted control mice. CCT018159 also decreased plasma ACTH levels, and POMC and PTTG1 mRNA levels in the tumor cells.[2]
存储条件: store at low temperaturePowder: -20°C for 3 years | In solvent: -80°C for 1 year
溶解度: DMSO : 112.5 mg/mL (319.3 mM)
关键字: CCT 018159 | CCT018159 | CCT-018159
相关产品: MI-3 | NVP-2 | TJ191 | Bendamustine hydrochloride | STAT5-IN-2 | ODQ | Lycorine | OTS514 | Actein | Tandutinib
相关库: Bioactive Compounds Library Max | Inhibitor Library | Anti-Cancer Active Compound Library | Exosome Compound Library | Bioactive Compound Library
化合物CCT018159 T21872信息由TargetMol中国为您提供,如您想了解更多关于化合物CCT018159 T21872报价、型号、参数等信息,欢迎来电或留言咨询。
注:该产品未在中华人民共和国食品药品监督管理部门申请医疗器械注册和备案,不可用于临床诊断或治疗等相关用途